My Bibliography

select

McDermott A, Kim K, Kasper S, Ho SM, Leung YK. The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells. Oncotarget. 2022;13:46-60. doi: 10.18632/oncotarget.28169. eCollection 2022. PubMed PMID: 35018219; PubMed Central PMCID: PMC8741193.

select

Lee JE, Cho SG, Ko SG, Ahrmad SA, Puga A, Kim K. Regulation of a long noncoding RNA MALAT1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues. Biochem Biophys Res Commun. 2020 Nov 19;532(4):563-569. doi: 10.1016/j.bbrc.2020.08.053. Epub 2020 Sep 6. PubMed PMID: 32900487; PubMed Central PMCID: PMC7572814.

select

Khanal T, Leung YK, Jiang W, Timchenko N, Ho SM, Kim K. NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries. FASEB J. 2019 Jul;33(7):8335-8348. doi: 10.1096/fj.201801881RR. Epub 2019 Apr 16. PubMed PMID: 30991008; PubMed Central PMCID: PMC6593879.

select

Khanal T, Choi K, Leung YK, Wang J, Kim D, Janakiram V, Cho SG, Puga A, Ho SM, Kim K. Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer. Sci Rep. 2017 Sep 6;7(1):10662. doi: 10.1038/s41598-017-11106-2. PubMed PMID: 28878246; PubMed Central PMCID: PMC5587550.

select

Ko SG, Yin CS, Du B, Kim KH. Herbal Medicines for Inflammatory Diseases 2016. Mediators Inflamm. 2016;2016:8270323. doi: 10.1155/2016/8270323. Epub 2016 Oct 25. PubMed PMID: 27847408; PubMed Central PMCID: PMC5099452.

select

Gandhy SU, Imanirad P, Jin UH, Nair V, Hedrick E, Cheng Y, Corton JC, Kim K, Safe S. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC. Oncotarget. 2015 Sep 22;6(28):26359-72. doi: 10.18632/oncotarget.4560. PubMed PMID: 26317792; PubMed Central PMCID: PMC4694907.

select

Khanal T, Kim D, Johnson A, Choubey D, Kim K. Deregulation of NR2E3, an orphan nuclear receptor, by benzo(a)pyrene-induced oxidative stress is associated with histone modification status change of the estrogen receptor gene promoter. Toxicol Lett. 2015 Sep 17;237(3):228-36. doi: 10.1016/j.toxlet.2015.06.1708. Epub 2015 Jul 3. PubMed PMID: 26149760; PubMed Central PMCID: PMC4524348.

select

Ko SG, Yin CS, Du B, Kim K. Herbal medicines for inflammatory diseases. Mediators Inflamm. 2014;2014:982635. doi: 10.1155/2014/982635. Epub 2014 Dec 24. PubMed PMID: 25609893; PubMed Central PMCID: PMC4290032.

select

Yang WS, Chadalapaka G, Cho SG, Lee SO, Jin UH, Jutooru I, Choi K, Leung YK, Ho SM, Safe S, Kim K. The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis. Neoplasia. 2014 Dec;16(12):1059-69. doi: 10.1016/j.neo.2014.09.011. PubMed PMID: 25499219; PubMed Central PMCID: PMC4309261.

select

Jutooru I, Guthrie AS, Chadalapaka G, Pathi S, Kim K, Burghardt R, Jin UH, Safe S. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents. Mol Cell Biol. 2014 Jul;34(13):2382-95. doi: 10.1128/MCB.01602-13. Epub 2014 Apr 14. PubMed PMID: 24732804; PubMed Central PMCID: PMC4054319.

select

Zhang Z, Kim K, Li X, Moreno M, Sharp T, Goodheart MJ, Safe S, Dupuy AJ, Amendt BA. MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression. Mol Cancer Ther. 2014 Jul;13(7):1942-51. doi: 10.1158/1535-7163.MCT-13-1000. Epub 2014 Apr 30. PubMed PMID: 24785257; PubMed Central PMCID: PMC4090280.

select

Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013 Mar 28;32(13):1616-25. doi: 10.1038/onc.2012.193. Epub 2012 May 21. PubMed PMID: 22614017; PubMed Central PMCID: PMC3484248.

select

Chadalapaka G, Jutooru I, Sreevalsan S, Pathi S, Kim K, Chen C, Crose L, Linardic C, Safe S. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors. Int J Cancer. 2013 Feb 15;132(4):795-806. doi: 10.1002/ijc.27730. Epub 2012 Aug 3. PubMed PMID: 22815231; PubMed Central PMCID: PMC3527649.

select

Gandhy SU, Kim K, Larsen L, Rosengren RJ, Safe S. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer. 2012 Nov 30;12:564. doi: 10.1186/1471-2407-12-564. PubMed PMID: 23194063; PubMed Central PMCID: PMC3522018.

select

Park YY, Jung SY, Jennings NB, Rodriguez-Aguayo C, Peng G, Lee SR, Kim SB, Kim K, Leem SH, Lin SY, Lopez-Berestein G, Sood AK, Lee JS. FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis. 2012 Oct;33(10):1843-53. doi: 10.1093/carcin/bgs167. Epub 2012 May 10. PubMed PMID: 22581827; PubMed Central PMCID: PMC3529559.

select

Kim K, Chadalapaka G, Pathi SS, Jin UH, Lee JS, Park YY, Cho SG, Chintharlapalli S, Safe S. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters. Mol Cancer Ther. 2012 Sep;11(9):1852-62. doi: 10.1158/1535-7163.MCT-12-0181. Epub 2012 Jun 29. PubMed PMID: 22752225; PubMed Central PMCID: PMC3632183.

select

Lee SO, Andey T, Jin UH, Kim K, Singh M, Safe S. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53. Oncogene. 2012 Jul 5;31(27):3265-76. doi: 10.1038/onc.2011.504. Epub 2011 Nov 14. PubMed PMID: 22081070; PubMed Central PMCID: PMC3299891.

select

Liu X, Jutooru I, Lei P, Kim K, Lee SO, Brents LK, Prather PL, Safe S. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer. Mol Cancer Ther. 2012 Jul;11(7):1421-31. doi: 10.1158/1535-7163.MCT-12-0026. Epub 2012 May 2. PubMed PMID: 22553354; PubMed Central PMCID: PMC4924623.

select

Kim K, Chadalapaka G, Lee SO, Yamada D, Sastre-Garau X, Defossez PA, Park YY, Lee JS, Safe S. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene. 2012 Feb 23;31(8):1034-44. doi: 10.1038/onc.2011.296. Epub 2011 Jul 18. PubMed PMID: 21765466; PubMed Central PMCID: PMC3288192.

select

Park YY, Kim K, Kim SB, Hennessy BT, Kim SM, Park ES, Lim JY, Li J, Lu Y, Gonzalez-Angulo AM, Jeong W, Mills GB, Safe S, Lee JS. Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer. EMBO Mol Med. 2012 Jan;4(1):52-67. doi: 10.1002/emmm.201100187. Epub 2011 Dec 15. PubMed PMID: 22174013; PubMed Central PMCID: PMC3376834.

select

Zhang S, Kim K, Jin UH, Pfent C, Cao H, Amendt B, Liu X, Wilson-Robles H, Safe S. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells. Mol Cancer Ther. 2012 Jan;11(1):108-18. doi: 10.1158/1535-7163.MCT-11-0548. Epub 2011 Oct 27. PubMed PMID: 22034498; PubMed Central PMCID: PMC3256275.

select

Claerhout S, Lim JY, Choi W, Park YY, Kim K, Kim SB, Lee JS, Mills GB, Cho JY. Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer. PLoS One. 2011;6(9):e24662. doi: 10.1371/journal.pone.0024662. Epub 2011 Sep 9. PubMed PMID: 21931799; PubMed Central PMCID: PMC3170379.

select

Yoon K, Lee SO, Cho SD, Kim K, Khan S, Safe S. Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors. Carcinogenesis. 2011 Jun;32(6):836-42. doi: 10.1093/carcin/bgr040. Epub 2011 Mar 1. PubMed PMID: 21362629; PubMed Central PMCID: PMC3106434.

select

Kim K, Burghardt R, Barhoumi R, Lee SO, Liu X, Safe S. MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells. J Mol Endocrinol. 2011 Apr;46(2):67-79. doi: 10.1677/JME-10-0110. Print 2011 Apr. PubMed PMID: 21169420; PubMed Central PMCID: PMC3069690.

select

Lee SO, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K, Wang H, Safe S. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res. 2010 Sep 1;70(17):6824-36. doi: 10.1158/0008-5472.CAN-10-1992. Epub 2010 Jul 21. PubMed PMID: 20660371; PubMed Central PMCID: PMC2988472.

select

Li X, Mertens-Talcott SU, Zhang S, Kim K, Ball J, Safe S. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. Endocrinology. 2010 Jun;151(6):2462-73. doi: 10.1210/en.2009-1150. Epub 2010 Apr 9. PubMed PMID: 20382698; PubMed Central PMCID: PMC2875816.

select

Wu F, Xu R, Kim K, Martin J, Safe S. In vivo profiling of estrogen receptor/specificity protein-dependent transactivation. Endocrinology. 2008 Nov;149(11):5696-705. doi: 10.1210/en.2008-0720. Epub 2008 Jul 17. PubMed PMID: 18635651; PubMed Central PMCID: PMC2584598.

select

Safe S, Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol. 2008 Nov;41(5):263-75. doi: 10.1677/JME-08-0103. Epub 2008 Sep 4. Review. PubMed PMID: 18772268; PubMed Central PMCID: PMC2582054.

select

Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007 Jul 6;317(5834):121-4. doi: 10.1126/science.1140485. PubMed PMID: 17615358.

select

Khan S, Barhoumi R, Burghardt R, Liu S, Kim K, Safe S. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells. Mol Endocrinol. 2006 Sep;20(9):2199-214. doi: 10.1210/me.2006-0100. Epub 2006 May 4. PubMed PMID: 16675542.

select

Abdelrahim M, Ariazi E, Kim K, Khan S, Barhoumi R, Burghardt R, Liu S, Hill D, Finnell R, Wlodarczyk B, Jordan VC, Safe S. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Res. 2006 Feb 15;66(4):2459-67. doi: 10.1158/0008-5472.CAN-05-3132. PubMed PMID: 16489053.

select

Kim K, Barhoumi R, Burghardt R, Safe S. Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol Endocrinol. 2005 Apr;19(4):843-54. doi: 10.1210/me.2004-0326. Epub 2005 Jan 6. PubMed PMID: 15637147.

select

Lee JE, Kim K, Sacchettini JC, Smith CV, Safe S. DRIP150 coactivation of estrogen receptor alpha in ZR-75 breast cancer cells is independent of LXXLL motifs. J Biol Chem. 2005 Mar 11;280(10):8819-30. doi: 10.1074/jbc.M413184200. Epub 2004 Dec 28. PubMed PMID: 15625066.

select

Safe S, Kim K. Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol. 2004;77:1-36. doi: 10.1016/S0079-6603(04)77001-4. Review. PubMed PMID: 15196889.

select

Kim K, Thu N, Saville B, Safe S. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Mol Endocrinol. 2003 May;17(5):804-17. doi: 10.1210/me.2002-0406. Epub 2003 Feb 6. PubMed PMID: 12576490.

select

Porter W, Wang F, Duan R, Qin C, Castro-Rivera E, Kim K, Safe S. Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. J Mol Endocrinol. 2001 Feb;26(1):31-42. doi: 10.1677/jme.0.0260031. PubMed PMID: 11174852.

select

Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 1998 Apr;19(4):611-6. doi: 10.1093/carcin/19.4.611. PubMed PMID: 9600345.